Literature DB >> 27280869

Timing of percutaneous cholecystostomy tube removal: systematic review.

Daniele Macchini1, Luca Degrate, Massimo Oldani, Davide Leni, Pietro Padalino, Fabrizio Romano, Luca Gianotti.   

Abstract

INTRODUCTION: Percutaneous cholecystostomy (PC) is an effective procedure to treat moderate or severe acute cholecystitis (AC) in high-risk patients. The ideal timing of the drainage removal is argued. The aim of this study is to analyze our experience and perform a systematic review about the ideal timing of a percutaneous cholecystostomy (PC) tube removal. EVIDENCE ACQUISITION: A web-based literature search was performed and studies reporting the length of the catheter maintenance were analyzed. A regression analysis between the timing of tube removal and morbidity, mortality and disease recurrence was performed. Patients who underwent PC as definitive treatment of moderate or severe acute cholecystitis at our institution between 2011 to 2015 were analyzed. Clinical and technical success, morbidity, mortality and recurrence rates were retrospectively retrieved from a perspective database. EVIDENCE SYNTHESIS: The systematic review yield to analyze 50 studies. None of them focused exclusively on outcome measures in relation to PC tube duration. The timing of the drain removal varied from 2 to 193 days. Regression analyses showed no correlation between length of tube maintenance and the considered outcomes. We studied 35 patients. The median age was 78 (range 52-94) and 88.5% had an ASA score ≥3. P-POSSUM estimated morbidity was 68.7% (range 34.3-99.0) and mortality was 15.8% (range 1.9-80.2). Clinical success was 97.1%. Procedure-related morbidity was 34.3%: 2 abscess, 1 bleeding, 1 biloma and 8 tube dislodgment. Biliary leakage was not observed. The observed 30-day overall mortality was 11.4%. The median follow-up was 16 months. Recurrence rate was 12.1%.
CONCLUSIONS: PC is an effective procedure in high-risk patients with moderate or severe AC. At the moment there is no evidence whether the duration of PC tube may affect outcome.

Entities:  

Mesh:

Year:  2016        PMID: 27280869

Source DB:  PubMed          Journal:  Minerva Chir        ISSN: 0026-4733            Impact factor:   1.000


  5 in total

Review 1.  Gallbladder: Role of Interventional Radiology.

Authors:  Matthew Antalek; Ahsun Riaz; Albert A Nemcek
Journal:  Semin Intervent Radiol       Date:  2021-08-10       Impact factor: 1.780

Review 2.  Image-guided percutaneous cholecystostomy: a comprehensive review.

Authors:  Shayeri Roy Choudhury; Pankaj Gupta; Shikha Garg; Naveen Kalra; Mandeep Kang; Manavjit Singh Sandhu
Journal:  Ir J Med Sci       Date:  2021-05-22       Impact factor: 1.568

Review 3.  Management of Patients With Acute Cholecystitis After Percutaneous Cholecystostomy: From the Acute Stage to Definitive Surgical Treatment.

Authors:  Yu-Liang Hung; Chang-Mu Sung; Chih-Yuan Fu; Chien-Hung Liao; Shang-Yu Wang; Jun-Te Hsu; Ta-Sen Yeh; Chun-Nan Yeh; Yi-Yin Jan
Journal:  Front Surg       Date:  2021-04-15

4.  Percutaneous cholecystostomy as a definitive treatment for moderate and severe acute acalculous cholecystitis: a retrospective observational study.

Authors:  Bai-Qing Chen; Guo-Dong Chen; Feng Xie; Xue Li; Xue Mao; Bao Jia
Journal:  BMC Surg       Date:  2021-12-27       Impact factor: 2.102

5.  Percutaneous cholecystostomy in the management of acute cholecystitis - 10 years of experience.

Authors:  Petr Dvorak; Petr Hoffmann; Ondrej Renc; Tomas Dusek; Stanislav Rejchrt; Ondrej Slezak; Pavel Vyroubal
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2019-05-05       Impact factor: 1.195

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.